HomeNOXOF • OTCMKTS
add
Noxopharm Ltd
Previous close
$0.045
Year range
$0.030 - $0.045
Market cap
30.68M AUD
Avg Volume
77.00
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
Market news
Financials
Income Statement
Revenue
Net income
| (AUD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 594.16K | -55.40% |
Operating expense | 1.02M | -27.86% |
Net income | -540.10K | 88.78% |
Net profit margin | -90.90 | 74.85% |
Earnings per share | — | — |
EBITDA | -1.17M | 53.29% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (AUD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.32M | -22.89% |
Total assets | 6.78M | -33.02% |
Total liabilities | 1.29M | 22.12% |
Total equity | 5.50M | — |
Shares outstanding | 292.24M | — |
Price to book | 2.25 | — |
Return on assets | -43.17% | — |
Return on capital | -53.30% | — |
Cash Flow
Net change in cash
| (AUD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -540.10K | 88.78% |
Cash from operations | -1.41M | 65.76% |
Cash from investing | — | — |
Cash from financing | 0.00 | 100.00% |
Net change in cash | -1.42M | 65.17% |
Free cash flow | -733.19K | 53.29% |
About
Founded
2015
Headquarters
Website
Employees
1,000
